Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
12,834.00    -520.00 (-3.89%)
Bid:
12,910.00
Ask:
12,920.00
Spread: 10.00 (0.077%)
Market Cap: £199.04b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

US regulator FDA greenlights AbbVie and AstraZeneca's cancer treatment
20 Feb 2026

US regulator FDA greenlights AbbVie and AstraZeneca's cancer treatment

(Alliance News) - AbbVie Inc and AstraZeneca PLC on Friday hailed a regulatory win for their joint cancer treatment programme.

AstraZeneca's Calquence leukaemia treatment gets US FDA approval
20 Feb 2026

AstraZeneca's Calquence leukaemia treatment gets US FDA approval

(Sharecast News) - AstraZeneca said on Friday that the US Food and Drug Administration has approved its 'Calquence', or acalabrutinib, in combination ...

LONDON BROKER RATINGS: Three brokers cut Unilever to 'hold' from 'buy'
18 Feb 2026

LONDON BROKER RATINGS: Three brokers cut Unilever to 'hold' from 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:

LONDON BROKER RATINGS: RBC cuts Schroders, LBBW says 'hold' Unilever
16 Feb 2026

LONDON BROKER RATINGS: RBC cuts Schroders, LBBW says 'hold' Unilever

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Shore Capital lowers AstraZeneca to 'hold'
13 Feb 2026

Shore Capital lowers AstraZeneca to 'hold'

(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings out...

LONDON MARKET MIDDAY: Stocks edge lower ahead of US CPI data
13 Feb 2026

LONDON MARKET MIDDAY: Stocks edge lower ahead of US CPI data

(Alliance News) - Stock prices in London were modestly lower at midday on Friday, with sentiment cautious ahead of US inflation data and the Munich Se...

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx
13 Feb 2026

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

AstraZeneca rises on positive trial results for asthma therapy
13 Feb 2026

AstraZeneca rises on positive trial results for asthma therapy

(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere.